Johnson & Johnson Share Holder Equity 2010-2024 | JNJ

Johnson & Johnson share holder equity for the quarter ending September 30, 2024 was $70.158B, a 1.5% decline year-over-year.

  • Johnson & Johnson share holder equity for 2023 was $68.774B, a 10.46% decline from 2022.
  • Johnson & Johnson share holder equity for 2022 was $76.804B, a 3.76% increase from 2021.
  • Johnson & Johnson share holder equity for 2021 was $74.023B, a 16.98% increase from 2020.

Johnson & Johnson Share Holder Equity 2010-2024 | JNJ

  • Johnson & Johnson share holder equity for 2023 was $68.774B, a 10.46% decline from 2022.
  • Johnson & Johnson share holder equity for 2022 was $76.804B, a 3.76% increase from 2021.
  • Johnson & Johnson share holder equity for 2021 was $74.023B, a 16.98% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
AbbVie (ABBV)$312.7B
Merck (MRK)$250.9B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B